The increasing prevalence of chronic and hospital-acquired infections produced by
multidrug-resistant (MDR) or extensively drug-resistant (XDR) Pseudomonas aeruginosa …

Chronic lower airway infection with Pseudomonas aeruginosa is a major contributor to
morbidity and mortality in individuals suffering from the genetic disease cystic fibrosis (CF) …

The 2013 Infection Prevention and Control (IP&C) Guideline for Cystic Fibrosis (CF) was
commissioned by the CF Foundation as an update of the 2003 Infection Control Guideline …

Infection of the airways remains the primary cause of morbidity and mortality in persons with
cystic fibrosis (CF). This review describes salient features of the epidemiologies of microbial …

SUMMARY A select group of microorganisms inhabit the airways of individuals with cystic
fibrosis. Once established within the pulmonary environment in these patients, many of …

Feigin and Cherry's Textbook of Pediatric Infectious Diseases helps you put the very latest
knowledge to work for your young patients with unparalleled coverage of everything from …

Bronchiectasis is a disease of renewed interest in light of an increase in prevalence and
increasing burden on international healthcare systems. There are no licensed therapies …

Despite significant advances in treatment strategies targeting the underlying defect in cystic
fibrosis (CF), airway infection remains an important cause of lung disease. In this two-part …

Pseudomonas aeruginosa isolates have a highly conserved core genome representing up
to 90% of the total genomic sequence with additional variable accessory genes, many of …

Rationale: Pseudomonas aeruginosa isolates from chronic cystic fibrosis lung infections
display multiple phenotypes indicating extensive population diversity. Objectives: We aimed …